ASTEC · NSE
Astec LifeSciences Limited
₹726.7
-3.77% (-₹28.45)
Prev. close
₹755.15
Volume
1,01,375
Delivery %
23.8%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Astec LifeSciences Limited
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives. It also provides herbicides, insecticides, and agrochemical intermediates. The company also exports its products. Further, it offers contract development and manufacturing operations. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited operates as a subsidiary of Godrej Agrovet Limited.
Details
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Mr. Deepak Jawaharlal Ochani
Headquarters
Mumbai
Employees
471
Website
godrejastec.comExchange
View on NSE ↗Key stats
Market cap
₹1,619.25 Cr
EPS (TTM)
₹-33.45
Beta (1Y · daily vs NIFTY 50)
0.80
Beta (5Y · monthly vs NIFTY 50)
1.16
Shares float
55.14 L
EPS · quarter ended Jun 2026
₹-8.40
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (consolidated), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹554.87 Cr | ₹676.57 Cr | ₹628.17 Cr | ₹458.18 Cr | ₹381.30 Cr | ₹448.15 Cr | |
| EBITDA | ₹119.48 Cr | ₹164.54 Cr | ₹89.31 Cr | ₹-26.87 L | ₹-60.58 Cr | ₹-1.55 Cr |
| ₹65.05 Cr | ₹89.86 Cr | ₹25.56 Cr | ₹-46.93 Cr | ₹-134.75 Cr | ₹-80.92 Cr | |
| Diluted EPS | ₹33.21 | ₹45.85 | ₹13.04 | ₹-23.93 | ₹-68.71 | ₹-37.79 |
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹678.00 Cr | ₹897.00 Cr | ₹979.00 Cr | ₹975.00 Cr | ₹881.00 Cr | ₹942.00 Cr | |
| ₹187.56 Cr | ₹279.37 Cr | ₹341.18 Cr | ₹493.89 Cr | ₹554.54 Cr | ₹448.93 Cr | |
| Stockholders' equity | ₹310.00 Cr | ₹397.00 Cr | ₹420.00 Cr | ₹370.00 Cr | ₹235.00 Cr | ₹390.00 Cr |
Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹-8.20 Cr | ₹23.60 Cr | ₹74.66 Cr | ₹10.22 Cr | ₹-8.40 Cr | ₹-80.71 Cr | |
| Investing cash flow | ₹-73.11 Cr | ₹-103.87 Cr | ₹-112.51 Cr | ₹-135.18 Cr | ₹-15.23 Cr | ₹-4.31 Cr |
| ₹81.00 Cr | ₹80.00 Cr | ₹38.00 Cr | ₹125.00 Cr | ₹24.00 Cr | ₹94.00 Cr | |
| Capital expenditure | ₹-102.53 Cr | ₹-103.98 Cr | ₹-117.26 Cr | ₹-135.50 Cr | ₹-21.82 Cr | ₹-5.54 Cr |
| End cash position | ₹32.94 L | ₹55.45 L | ₹47.34 L | ₹47.15 L | ₹57.54 L | ₹10.05 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21 | Dec 21 | Mar 22–Jun 22(2Q) | Sep 22–Mar 23(3Q) | Jun 23 | Sep 23–Dec 24(6Q) | Mar 25–Jun 25(2Q) | Jul 25–Sep 25(2Q) | Dec 25–Mar 26(2Q) | Jun 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.20% | 65.19% | 65.29% | 66.77% | 66.76% | 66.75% | 70.87% | 72.42% | 71.97% | 71.96% |
| Public | 34.80% | 34.81% | 34.71% | 33.23% | 33.24% | 33.25% | 29.13% | 27.58% | 28.03% | 28.04% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Basic Materials
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| UltraTech Cement Limited | ₹3.17 L Cr | ₹11,014 | 36.9 | 4.13 | 10.7% | 0.31 | +16.6% | -12.8% |
| JSW Steel Limited | ₹3.06 L Cr | ₹1,275.6 | 12.4 | 3.06 | 22.3% | 1.19 | +9.3% | +13.8% |
| Hindustan Zinc Limited | ₹2.42 L Cr | ₹596 | 14.2 | 10.69 | 61.1% | 0.39 | +18.6% | +31.0% |
| Asian Paints Limited | ₹2.35 L Cr | ₹2,451.3 | 49.3 | 11.01 | 20.2% | 0.18 | +5.1% | -1.1% |
| Tata Steel Limited | ₹2.28 L Cr | ₹187.29 | 20.7 | 2.23 | 10.6% | 0.90 | +6.2% | +9.3% |
| Hindalco Industries Limited | ₹2.18 L Cr | ₹986.5 | 13.3 | 1.59 | 9.8% | 0.73 | +15.0% | +31.5% |
| Grasim Industries Limited | ₹2.15 L Cr | ₹3,209.2 | 37.9 | 2.08 | 4.8% | 2.20 | +18.2% | +11.5% |
| Solar Industries India Limited | ₹1.71 L Cr | ₹18,815 | 86.1 | 27.25 | 26.7% | 0.29 | +30.6% | +27.0% |
| Vedanta Aluminium Metal Limited | ₹1.60 L Cr | ₹416.5 | 42.1 | — | — | — | — | — |
| Pidilite Industries Limited | ₹1.58 L Cr | ₹1,572.1 | 59.8 | 14.58 | 22.6% | 0.04 | +11.1% | -48.5% |
| JINDAL STEEL LIMITED | ₹1.11 L Cr | ₹1,103 | 41.1 | 2.19 | 6.6% | 0.44 | +5.5% | +4.7% |
| Astec LifeSciences Limited | ₹1,474.97 Cr | ₹661.95 | — | 3.78 | -20.7% | 1.15 | +17.9% | -20.9% |
Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.
Documents
IPO documents
Annual reports
Show all 19
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
2 indices
Weight is BSE’s own published index weight. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Astec LifeSciences addresses recent surge in trading volume, confirms regulatory compliance
Business Upturn · 20 hours ago
Astec LifeSciences Share Price Surges Sharply
Astec LifeSciences Limited shares surged, trading at ₹756.60, significantly above its 50-day SMA of ₹635.99, indicating a shift in its technical structure. This occurred despite the company reporting a standalone net loss of ₹18.74 crore for the June 2026 quarter. Investors are monitoring price stability, trading volume, and the company's path to profitability.